Publication: 2108

Publication: 2108

Phase II study of neoadjuvant therapy with docetaxel, cisplatin, panitumumab, and radiation therapy followed by surgery in patients with locally advanced adenocarcinoma of the distal esophagus (ACOSOG Z4051).

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Ann Oncol vol 25 (5) 1039-44

Year:: 2014
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:: 934 is parent abstract

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 3

Parents:: 934 972
Children:: None

Program:: OGC
Primary Committee:: GI
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, U10 CA180821, U10 CA180882

Corr. Author:
Authors:: A C Lockhart C E Reed P A Decker B F Meyers M K Ferguson A R Oeltjen J B Putnam S D Cassivi A J Montero T E Schefter

Networks:

Study: ACOSOG-Z4051
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords:: chemotherapy, epidermal growth factor receptor, esophageal cancer, esophagectomy, neoadjuvant therapy, radiation therapy